当前位置: 首页 > 期刊 > 《医学信息》 > 2019年第11期
编号:13387770
多索茶碱治疗慢性阻塞性肺疾病急性加重期患者的临床疗效(3)
http://www.100md.com 2019年3月19日 《医学信息》 2019年第11期
     [2]肖毅,蔡柏蔷.呼吸内科诊疗常规[M].第2版.北京:人民卫生出版社.

    [3]慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组.慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2017年更新版)[J].国际呼吸杂志,2017,37(14):1041-1057.

    [4]Shukla D,Chakraborty S,Singh S.Doxofylline:a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease[J].Expert Opin Pharmacother,2009(10):2343-2356.

    [5]van Mastbergen J,Jolas T,Allegra L,et al.The mechanism of action of doxofylline is unrelated to HDAC inhibition,PDE inhibition or adenosine receptor antagonism[J].Pulm Pharmacol Ther,2012,25(1):55-61.

    [6]Duffy N,Walker P,Diamantea F,et al.Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease:a prospective randomised controlled trial[J].Thorax,2005,60(9):713-717.

    [7]Lal D,Manocha S,Ray A,et al.Comparative study of the efficacy and safety of theophylline and doxofylline in patients with bronchial asthma and chronic obstructive pulmonary disease[J].J Basic Clin Physiol Pharmacol,2015(26):443-451.

    [8]袁雅冬,趙芳,王淑梅.左氧氟沙星对慢性阻塞性肺疾病急性加重患者的多索茶碱血药浓度的影响研究[J].中国药房,2017 ,37(6):3206-3209.

    [9]杨良芹,金桂兰.左氧氟沙星与多索茶碱联用引起中枢神经兴奋、失眠1例[J].中国医院用药评价与分析,2013,13(7):671-672.

    收稿日期:2019-3-27;修回日期:2019-4-7

    编辑/杜帆, http://www.100md.com(章勇 李秀)
上一页1 2 3